La farmacéutica Novartis ha presentado Secukinumab, un biológico que tiene como objetivo lograr un "PASI 90", es decir, un blanqueamiento de la piel y de las lesiones en un 90%, casi la totalidad del cuerpo. El nuevo fármaco, "superior" al resto de biológicos, fue presentado en el marco del Congreso Nacional de Dermatología y Venerología, celebrado en Sevilla.
|
etiquetas: psoriasis , medicamento , blanquear , 90%
Call your doctor at once if you have:
redness, warmth, or swelling under your skin;
cold sores, sores on your genital or anal area;
painful skin sores;
cough, shortness of breath, cough with red or pink mucus;
increased urination, pain or burning when you urinate;
sores or white patches in your mouth or throat (yeast infection or "thrush");
diarrhea, stomach pain; or
fever, chills, sweating, muscle pain, weight loss.
Common Cosentyx side effects may include:
diarrhea; or
cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Te he votado negativo sin querer. Perdón